Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
 Imidazole (CAS 25371-97-5) Market Report 2009-2016-2020 - EconoTimes)
Dublin, Sept. 19, 2016 -- Research and Markets has announced the addition of the "Global Market Report On 1-(3-Trifluoromethylphenyl)Imidazole 2016" report to their offering.
The Global Market Report on 1-(3-Trifluoromethylphenyl) Imidazole provides comprehensive data on 1-(3-Trifluoromethylphenyl) Imidazole global and regional markets including Europe, Asia, North America, Latin America, etc. The report captures 1-(3-Trifluoromethylphenyl) Imidazole market trends and pays close attention to 1-(3-Trifluoromethylphenyl) Imidazole.
The report is broken into three main parts including manufacturing methods & technology development, market landscape & trend analysis, and distribution policy.
In the manufacturing methods & technology development section, the main manufacturing methods of 1-(3-Trifluoromethylphenyl) Imidazole are introduced.
Key Topics Covered:
Part 1: Introduction of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 1: Brief Introduction of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 2: Product Identification
Chapter 3: Physical Properties
Chapter 4: Quality Specifications
Part 2: Manufacture Methods and Technology Development of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 1: Introduction of Main Manufacture Methods
Chapter 2: Introduction of Patent Manufacture Methods
Chapter 3: New Progress on the Manufacture Technology
Part 3: Application of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 1: Application Review
Chapter 2: End Products(Downstream Products) of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 3: New Applications of 1-(3-Trifluoromethylphenyl) Imidazole
Part 4: Production Situation of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 1: Current Production Situation
Chapter 2: Manufacturers in China
Chapter 3: Manufacturers Outside of China
Chapter 4: Production Trend Analysis
Part 5: Market Situation of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 1: Market Supply Status and Trend Forecast
Chapter 2: Downstream Consumer Market Analysis
Chapter 3: Supply and Demand Analysis and Forecast
Chapter 4: Price Analysis
Chapter 5: Import & Export Situation
Part 6: Distribution Policy of 1-(3-Trifluoromethylphenyl) Imidazole
Chapter 1: Market Size in Major Use Segments
Chapter 2: Major End Users
Chapter 3: Potential Users
Part 7: References
For more information about this report visit http://www.researchandmarkets.com/research/25vkpm/global_market
Related Topics: Electronic Chemicals
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
